<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">0006761</journal-id><journal-id journal-id-type="pubmed-jr-id">3392</journal-id><journal-id journal-id-type="nlm-ta">Dev Med Child Neurol</journal-id><journal-id journal-id-type="iso-abbrev">Dev Med Child Neurol</journal-id><journal-title-group><journal-title>Developmental medicine and child neurology</journal-title></journal-title-group><issn pub-type="ppub">0012-1622</issn><issn pub-type="epub">1469-8749</issn></journal-meta><article-meta><article-id pub-id-type="pmid">33386749</article-id><article-id pub-id-type="pmc">8603138</article-id><article-id pub-id-type="doi">10.1111/dmcn.14792</article-id><article-id pub-id-type="manuscript">HHSPA1745495</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Neurosurgical procedures for children with myelomeningocele after fetal or postnatal surgery: a comparative effectiveness study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>WORLEY</surname><given-names>GORDON</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5127-2514</contrib-id><xref ref-type="aff" rid="A1">1</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>GREENBERG</surname><given-names>RACHEL G</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>ROCQUE</surname><given-names>BRANDON G</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>LIU</surname><given-names>TIEBIN</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>DICIANNO</surname><given-names>BRAD E</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>CASTILLO</surname><given-names>JONATHAN P</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>WARD</surname><given-names>ELISABETH A</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>WILLIAMS</surname><given-names>TONYA R</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>BLOUNT</surname><given-names>JEFFREY P</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>WIENER</surname><given-names>JOHN S</given-names></name><xref ref-type="aff" rid="A8">8</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Pediatric Neurology and Developmental Medicine, Department of Pediatrics, Duke University Medical Center, Durham, NC;</aff><aff id="A2"><label>2</label>Division of Neonatology, Department of Pediatrics, Duke University Medical Center, Durham, NC;</aff><aff id="A3"><label>3</label>Duke Clinical Research Institute, Durham, NC;</aff><aff id="A4"><label>4</label>Division of Pediatric Neurosurgery, Department of Neurosurgery, Children&#x02019;s Hospital of Alabama, University of Alabama at Birmingham, Birmingham, AL;</aff><aff id="A5"><label>5</label>Division of Human Development and Disability, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA;</aff><aff id="A6"><label>6</label>Department of Physical Medicine and Rehabilitation, University of Pittsburgh School of Medicine, Pittsburgh, PA;</aff><aff id="A7"><label>7</label>Division of Developmental Pediatrics, Department of Pediatrics, Texas Children&#x02019;s Hospital, Baylor College of Medicine, Houston, TX;</aff><aff id="A8"><label>8</label>Division of Urology, Department of Surgery, Duke University Medical Center, Durham, NC, USA.</aff><author-notes><fn fn-type="equal" id="FN1"><label>*</label><p id="P1">These authors contributed equally to this study.</p></fn><corresp id="CR1">Correspondence to Gordon Worley, 408 Deming Road, Chapel Hill 27514, NC, USA. <email>gordon.worley@duke.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>13</day><month>11</month><year>2021</year></pub-date><pub-date pub-type="epub"><day>02</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="ppub"><month>11</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>11</month><year>2021</year></pub-date><volume>63</volume><issue>11</issue><fpage>1294</fpage><lpage>1301</lpage><!--elocation-id from pubmed: 10.1111/dmcn.14792--><abstract id="ABS1"><sec id="S1"><title>AIM</title><p id="P2">To compare the frequencies of neurosurgical procedures to treat comorbid conditions of myelomeningocele in patients who underwent fetal surgery versus postnatal surgery for closure of the placode.</p></sec><sec id="S2"><title>METHOD</title><p id="P3">By utilizing the National Spina Bifida Patient Registry in a comparative effectiveness study, 298 fetal surgery patients were matched by birthdate (&#x000b1;3mo) and spina bifida clinic site with one to three postnatal surgery patients (<italic>n</italic>=648). Histories were obtained by record review on enrollment and yearly subsequently. Multivariable Poisson regression was used to compare frequencies of procedures between cohorts, with adjustments for sex, ethnicity, insurance status, spinal segmental level of motor function, age at last visit recorded in the Registry, and, for shunt revision in shunted patients, age at cerebrospinal fluid (CSF) diversion.</p></sec><sec id="S3"><title>RESULTS</title><p id="P4">The median age at last visit was 4 years. In fully adjusted analyses in patients aged at least 12 months old, fetal surgery was associated with decreased frequency of CSF diversion for hydrocephalus by ventriculoperitoneal shunt insertion or endoscopic third ventriculostomy compared with postnatal surgery (46% vs 79%; incidence rate ratio=0.61; 95% confidence interval [CI] 0.53&#x02013;0.71; <italic>p</italic>&#x0003c;0.01). Over all ages, fetal surgery was associated with decreased frequency of Chiari decompression for brainstem dysfunction (3% vs 7%; incidence rate ratio=0.41; 95% CI 0.19&#x02013;0.88; <italic>p</italic>=0.02). Also over all ages, differences were not significant in frequencies of shunt revision in shunted patients (53% vs 55%; incidence rate ratio=0.87; 95% CI 0.69&#x02013;1.11; <italic>p</italic>=0.27), nor tethered cord release for acquired spinal cord dysfunction (18% vs 16%; incidence rate ratio=1.11; 95% CI 0.84&#x02013;1.47; <italic>p</italic>=0.46).</p></sec><sec id="S4"><title>INTERPRETATION</title><p id="P5">Even with the variations inherent in clinical practice, fetal surgery was associated with lower frequencies of CSF diversion and of Chiari decompression, independent of covariates.</p></sec></abstract></article-meta></front><body><p id="P6">Myelomeningocele, perhaps better called spina bifida aperta (see <xref rid="SD1" ref-type="supplementary-material">Appendix S1</xref>, <xref rid="SD1" ref-type="supplementary-material">online supporting information</xref> for a full explanation), is caused by failure of the caudal neuropore to close during embryological neurulation. This results in a midline defect in mesoderm-derived tissue (bone, muscle, and dura), through which the atypically formed spinal cord and leptomeninges protrude.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup></p><p id="P7">Traditionally myelomeningocele has been treated by postnatal closure of the placode. Its comorbid conditions of hydrocephalus, the Chiari II malformation, and spinal cord tethering often require subsequent neurosurgical procedures.<sup><xref rid="R3" ref-type="bibr">3</xref></sup></p><p id="P8">Cerebrospinal fluid (CSF) diversion is used to treat hydrocephalus. Insertion of a ventriculoperitoneal shunt (henceforth, shunt) was the only procedure used for this for decades, but it has risks of shunt dysfunction and infection.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> A newer option for CSF diversion, endoscopic third ventriculostomy (ETV), was developed to avoid the complications of shunting.<sup><xref rid="R4" ref-type="bibr">4</xref></sup></p><p id="P9">The Chiari II malformation is a congenital brain anomaly associated with myelomeningocele. Its principal features are abnormalities of the midbrain, cerebellum, and brainstem, and herniation of the cerebellar vermis, cerebellar tonsils, and medullary elements through the foramen magnum into the cervical spinal canal (henceforth, hindbrain herniation). These abnormalities are thought to result from changes in vectors of fetal brain growth that are caused by continuous CSF venting out the open neural tube defect.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> In some cases, the Chiari II malformation manifests with symptoms of brainstem dysfunction. Surgical decompression of the posterior fossa (Chiari decompression) benefits selected patients with a symptomatic Chiari II malformation.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> Tethering of the spinal placode to the overlying scar after myelomeningocele closure can lead to progressive worsening of spinal cord function and/or intractable pain that requires surgical release of the tethered cord.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> Shunt dysfunction and infection necessitate shunt revision.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> The neurosurgical procedures are only performed on patients with signs, symptoms, or other indications related to each condition. Therefore, in a large sample, their frequencies can be used as surrogates for the frequencies of the conditions themselves.</p><p id="P10">Fetal surgery for closure of myelomeningocele was first successfully performed in 1997.<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup> The surgical technique used was similar to postnatal surgery, but was done at 23 to 26 weeks gestational age through a hysterotomy.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> It is thought by most that fetal surgery eliminates CSF venting, normalizes CSF pressure dynamics, and thereby normalizes fetal brain growth patterns. This more typical pattern of brain growth in turn reverses fetal hindbrain herniation, relieving obstruction to CSF flow and thus preventing hydrocephalus.<sup><xref rid="R9" ref-type="bibr">9</xref></sup></p><p id="P11">Early experience with fetal surgery suggested that it decreased frequencies of CSF diversion and imaging evidence of the Chiari II malformation. However, it also increased risks of preterm delivery and uterine dehiscence.<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup> A randomized controlled trial of fetal surgery versus postnatal surgery was conducted to determine if the benefits of fetal surgery outweighed the risks. The Management of Myelomeningocele Study (MOMS) was funded by the National Institutes of Health<sup><xref rid="R12" ref-type="bibr">12</xref></sup> and ran from 2003 to 2010. Enrollment in the MOMS was stopped early, for proof of efficacy of fetal surgery.<sup><xref rid="R13" ref-type="bibr">13</xref></sup></p><p id="P12">Analysis of the MOMS participants aged at least 12 months old confirmed that fetal surgery was associated with a lower frequencies of CSF diversion<sup><xref rid="R13" ref-type="bibr">13</xref>&#x02013;<xref rid="R15" ref-type="bibr">15</xref></sup> and hindbrain herniation on magnetic resonance imaging, but that the risks of preterm birth and of uterine dehiscence were higher.<sup><xref rid="R13" ref-type="bibr">13</xref></sup></p><p id="P13">While the MOMS clearly showed the benefit of fetal surgery for some outcomes, the trial was performed in selected participants at the three most experienced centers, raising questions about the generalizability of the MOMS findings to other fetal surgery centers.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Since the MOMS results were published in 2011,<sup><xref rid="R13" ref-type="bibr">13</xref></sup> fetal surgery for myelomeningocele has become widely utilized in the United States and around the world, but there are still divergent opinions about its value among pediatric neurosurgeons.<sup><xref rid="R16" ref-type="bibr">16</xref></sup> Since 2011, there have been only four single-institution, retrospective, case&#x02013;control studies comparing frequencies of neurosurgical procedures in fetal surgery and postnatal surgery patients.<sup><xref rid="R17" ref-type="bibr">17</xref>&#x02013;<xref rid="R20" ref-type="bibr">20</xref></sup> Therefore, we sought to determine if relevant findings of the MOMS could be generalized to a larger, broader, and less selected patient population, a study made possible by using the National Spina Bifida Patient Registry (NSBPR).</p><p id="P14">The NSBPR is maintained and directed by the Centers for Disease Control and Prevention with the goal of improving the care of people with spina bifida through clinical research.<sup><xref rid="R21" ref-type="bibr">21</xref>&#x02013;<xref rid="R25" ref-type="bibr">25</xref></sup> It is the largest clinical database of patients with spina bifida in the world. Through 2017, the NSBPR had 35 participating clinics and had enrolled 8662 patients with all forms of spina bifida. From its inception, its purpose has been to provide nationwide data to study the clinical characteristics of patients with spina bifida, the treatments used for their comorbidities, and the outcomes of their treatments.<sup><xref rid="R21" ref-type="bibr">21</xref></sup> Because of its large sample size and the involvement of so many spina bifida clinics, the NSBPR is well suited to study typical outcomes in patients with myelomeningocele.<sup><xref rid="R24" ref-type="bibr">24</xref>&#x02013;<xref rid="R26" ref-type="bibr">26</xref></sup></p><p id="P15">A randomized controlled trial, like the MOMS, determines the efficacy of an intervention under ideal conditions. A comparative effectiveness study determines if a new intervention changes outcomes in the &#x02018;real world&#x02019;, outside of the ideal conditions of a randomized controlled trial. Comparative effectiveness studies are necessary because indications for interventions evolve in clinical practice<sup><xref rid="R27" ref-type="bibr">27</xref></sup> in known and unknown ways, resulting in clinical variations, in contrast to the rigid exclusion and inclusion criteria of a randomized controlled trial. Patient registries can be used for comparative effectiveness studies.<sup><xref rid="R27" ref-type="bibr">27</xref></sup></p><p id="P16">Variations by fetal surgery center in fetal surgery exclusion criteria have arisen since 2011, becoming less stringent today than they were during the MOMS.<sup><xref rid="R28" ref-type="bibr">28</xref></sup> Two types of fetal surgery are now done for placode closure: via hysterotomy and by fetoscopy. Variations also exist in postnatal management. Frequencies of CSF diversion and Chiari decompression vary among spina bifida clinics that participated in our study<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup> and two types of CSF diversion are now used to treat hydrocephalus: shunt insertion and ETV. These variations are all justifications for our comparative effectiveness study.</p><p id="P17">The aim of this study was therefore to utilize the NSBPR to evaluate the comparative effectiveness of fetal surgery and postnatal surgery in patients with myelomeningocele for CSF diversion (shunt insertion or ETV), shunt revision in shunted patients, Chiari decompression, and tethered cord release. Outcomes were assessed in time frames consistent with those used by the MOMS (age &#x02265;12mo for assessment of CSF diversion status and at any age for other outcomes).</p><sec id="S5"><title>METHOD</title><p id="P18">Each of the individual spina bifida clinics that contributed data to this study obtained approval from its own institutional review board. There was no multisite institutional review board approval. The standard methods used by the NSBPR for institutional review board approval, data collection, data management, and data quality control have been described previously<sup><xref rid="R21" ref-type="bibr">21</xref>&#x02013;<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup> and are presented in detail in <xref rid="SD1" ref-type="supplementary-material">Appendix S2</xref> (<xref rid="SD1" ref-type="supplementary-material">online supporting information</xref>). Assessment of category of spinal segmental level of motor function (henceforth, motor level) was done by a standard physical examination at the last visit recorded in the NSBPR (<xref rid="SD1" ref-type="supplementary-material">Appendix S2</xref>).</p><p id="P19">Patients could be enrolled at any age. Medical and surgical histories were collected retrospectively by record review on enrollment and then prospectively once per year subsequently. Previously incomplete histories could be supplemented at any visit, making the history at the last visit both the most up to date and most complete. Data analyzed for this study were collected and entered from 2009 through 2017.</p><p id="P20">The primary outcome was the frequency of CSF diversion. This variable combined shunt insertion alone, ETV alone, and the combination of ETV and shunt insertion. Secondary outcomes were frequencies of shunt revision in shunted patients (which included patients with shunt insertion alone or with the combination of ETV and shunt insertion), Chiari decompression, and tethered cord release.</p><p id="P21">The study population was drawn from all patients with myelomeningocele born from 1997, the year of the first successful fetal surgery,<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup> through 2017. Each fetal surgery patient was matched with one to three postnatal surgery patients by date of birth (&#x000b1;3mo) and by spina bifida clinic site of care. If more than three postnatal surgery patients could be matched with a fetal surgery patient, three postnatal surgery patients were randomly selected from among those who matched. Fetal surgery patients for whom there were no matching postnatal surgery patients were excluded. The entire study population was used for all analyses, with these exceptions: (1) for comparisons of the frequencies of CSF diversion, the study population was limited to fetal surgery patients and matched postnatal surgery patients who were both at least 12 months old at the last visit, the age used for first their analysis by the MOMS;<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R10" ref-type="bibr">10</xref></sup> and (2) for comparison of frequencies of shunt revision ever (henceforth, shunt revision), the study population was limited to patients who had had a shunt inserted.</p><sec id="S6"><title>Statistical analyses</title><p id="P22">Fisher&#x02019;s exact test was used to compare the proportion of fetal surgery in patients born in two eras, based on when the results of the MOMS were published: (1) January 1997 through December 2010, and (2) January 2011 through December 2017. Fisher&#x02019;s exact test was also used to test associations of the distributions of motor levels with CSF diversion frequency in each cohort.</p><p id="P23">Univariable Poisson regression with robust variance estimators conditioning on the matched pair was used to evaluate both the differences in frequencies of sociodemographic characteristics and motor levels between cohorts, as well as the associations of each sociodemographic covariate with the frequency of each of the four neurosurgical procedures. A similar analysis was done for categories of motor levels with the frequencies of all four outcomes. Univariable linear regression conditioning on the matched pair was used to compare the age at last visit recorded in the NSBPR and age at CSF diversion in the two cohorts.</p><p id="P24">Multivariable Poisson regression with robust variance estimators conditioning on the matched pair was used to evaluate the differences in frequencies of outcomes between the cohorts after adjusting for covariates. Covariates included in the models were determined a priori: male sex, non-Hispanic white ethnicity, private insurance, motor level, and age at last visit recorded in the NSBPR. For the outcome of shunt revision among shunted patients, age at initial CSF diversion was also included as a covariate.</p><p id="P25">The Poisson regression method was used instead of logistic regression because the odds ratio obtained using logistic regression overestimates the risk ratio when the outcome is not rare (&#x0003e;10%), which was the case for multiple outcomes.<sup><xref rid="R29" ref-type="bibr">29</xref>&#x02013;<xref rid="R32" ref-type="bibr">32</xref></sup> Results of regression analyses are presented as incidence rate ratios or coefficients with 95% confidence intervals (CIs); <italic>p</italic>-values less than 0.05 were considered significant. Analyses were conducted using Stata version 16.0 (Statcorp, College Station, TX, USA).</p></sec></sec><sec id="S7"><title>RESULTS</title><p id="P26">Of the 8662 patients enrolled in the NSBPR through December 2017, 6410 patients were born in 1997 or later and, of these, 4872 had myelomeningocele. From these, 321 fetal surgery patients were identified. Relative to the number of patients enrolled in the NSBPR at the time, the proportion of fetal surgery patients increased significantly after results of the MOMS were reported in 2011<sup><xref rid="R13" ref-type="bibr">13</xref></sup> (<xref rid="F1" ref-type="fig">Fig. 1</xref>). Of the 321 fetal surgery patients, 298 patients were matched for date of birth and spina bifida clinic site to 648 postnatal surgery patients at 25 spina bifida clinic sites of care, and the remaining 23 unmatched fetal surgery patients were excluded from analysis. <xref rid="SD1" ref-type="supplementary-material">Figure S1</xref> (<xref rid="SD1" ref-type="supplementary-material">online supporting information</xref>) presents the distribution of patient in the study by spina bifida clinic site.</p><p id="P27">The fetal surgery cohort was more likely to be non-Hispanic white and to have private insurance, and was less likely to be non-Hispanic black or Hispanic. Sex distribution was not different between the two cohorts (<xref rid="T1" ref-type="table">Table 1</xref>). Demographics of the 23 fetal surgery patients excluded from analysis were similar to those included (48% male, 82% non-Hispanic white, and 65% with private insurance). In addition, we found that every sociodemographic characteristic, except male sex and Hispanic ethnicity, was significantly associated with at least one outcome in the whole study population (<xref rid="SD1" ref-type="supplementary-material">Table S1</xref>, <xref rid="SD1" ref-type="supplementary-material">online supporting information</xref>).</p><p id="P28">Relative to the frequency of having a sacral motor level, fetal surgery patients had lower odds ratios of having either a thoracic or a high lumber motor level than did the postnatal cohort (<xref rid="T1" ref-type="table">Table 1</xref>). In addition, in unadjusted analyses, more rostral motor levels were related to greater frequencies of CSF diversion and of Chiari decompression (<xref rid="SD1" ref-type="supplementary-material">Table S2</xref>, <xref rid="SD1" ref-type="supplementary-material">online supporting information</xref>). For both cohorts individually, the distribution of motor level categories was significantly associated with frequency of CSF diversion (<xref rid="SD1" ref-type="supplementary-material">Table S3</xref>, <xref rid="SD1" ref-type="supplementary-material">online supporting information</xref>).</p><p id="P29">The median age at last visit of the cohort was 4 years (25th&#x02013;75th centile: 1y 8mo&#x02013;11y 4mo) and mean age was 6 years 4 months. Mean ages were not significantly different between cohorts (<xref rid="T1" ref-type="table">Table 1</xref>). The median age at first CSF diversion was 91 days (30&#x02013;153d) for the fetal surgery cohort, compared with 0 days (0&#x02013;31d) for the postnatal surgery cohort (<italic>p</italic>=0.03). We therefore adjusted for age at CSF diversion in the analysis of shunt revisions in shunted patients; this was not applicable to other analyses.</p><p id="P30">We found that the frequencies components of the CSF diversion variable were: shunt only 86 out of 239 (36%); ETV only 14 out of 239 (6%); and both ETV and shunt 10 out of 239 (4%). In adjusted analyses, fetal surgery was associated with a significantly lower risk of CSF diversion and of Chiari decompression. The differences in frequencies between cohorts were not significant for tethered cord release or for shunt revision in shunted patients (<xref rid="T2" ref-type="table">Table 2</xref>).</p></sec><sec id="S8"><title>DISCUSSION</title><p id="P31">Our comparative effectiveness study found that CSF diversion frequency at age 12 months or older was lower after fetal surgery (46%) than after postnatal surgery (79%), in concordance with the main finding of the MOMS. It thereby directly and independently addressed the generalizability of this MOMS finding. Fetal surgery has been found to reverse fetal hindbrain herniation more frequently than postnatal surgery.<sup><xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup> Reversal of fetal hindbrain herniation was associated with absence of postnatal hydrocephalus, suggesting a mechanism for the lower frequency in CSF diversion frequency after fetal surgery.<sup><xref rid="R20" ref-type="bibr">20</xref></sup> Neither Tulipan et al.,<sup><xref rid="R14" ref-type="bibr">14</xref></sup> reporting results from the MOMS, nor Flanders et al.<sup><xref rid="R20" ref-type="bibr">20</xref></sup> found an association between anatomic levels of lesion and CSF diversion frequency in either their fetal surgery cohort, or in their postnatal surgery cohort. In contrast, we found significant associations between distributions of patients in categories of motor levels and CSF diversion frequencies in both cohorts (<xref rid="SD1" ref-type="supplementary-material">Table S3</xref>). We therefore adjusted for category of motor level in this analysis. In common with previous reports,<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup> we found that the age at CSF diversion was significantly older in fetal surgery patients.</p><p id="P32">We found a significantly lower frequency of Chiari decompression after fetal surgery (10 out of 298, 3%) than after postnatal surgery (45 out of 648, 7%). In contrast, Houtrow et al.,<sup><xref rid="R15" ref-type="bibr">15</xref></sup> studying MOMS outcomes at school age, did not (3 out of 79, 4% vs 9 out of 82, 11%). The most likely explanation for this discrepancy is the greater statistical power of our study from its larger study population. Kim et al.<sup><xref rid="R26" ref-type="bibr">26</xref></sup> found that more rostral motor level categories were associated with more frequent Chiari decompression, a finding that we confirmed and adjusted for in this analysis.</p><p id="P33">In our study, the frequencies of shunt revisions in shunted patients were not significantly different between cohorts. Flanders et al. also found no significant difference in shunt revision frequency between cohorts.<sup><xref rid="R20" ref-type="bibr">20</xref></sup> Houtrow et al.,<sup><xref rid="R15" ref-type="bibr">15</xref></sup> studying frequencies of shunt insertion ever in MOMS school-age children, found that significantly fewer fetal surgery participants had had shunt revisions compared to postnatal surgery participants.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> The reasons for this discordance are unclear. We matched for clinic site to control partially for the wide variation in indications for shunt revision in myelomeningocele among pediatric neurosurgeons,<sup><xref rid="R33" ref-type="bibr">33</xref></sup> reasoning from experience that neurosurgeons in the same clinic tend to have similar indications for most procedures. We noted that our difference in frequencies of shunt revision in shunted patients between cohorts was small (53% vs 55%), despite the longer time-at-risk for postnatal surgery patients because of their slightly older age at last visit and the shorter time-at-risk for fetal surgery patients because of their older age at CSF diversion. We found no relationship between shunt revision frequency and motor level.</p><p id="P34">Finally, in adjusted analysis, we found that tethered cord release was not significantly more frequent in fetal surgery patients. In contrast, Houtrow et al. found a higher frequency of tethered cord release in the MOMS fetal surgery cohort.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> The frequency of symptomatic tethered cord increases through childhood,<sup><xref rid="R6" ref-type="bibr">6</xref></sup> but this is unlikely to be the sole explanation for this discrepancy in findings, given the closeness of the mean ages at ascertainment of outcomes in our study and in Houtrow et al.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> (6y 4mo vs 7y 10mo). We found no relationship between motor level and frequency of tethered core release in the study population.</p><p id="P35">Calling our study a comparative effectiveness study is justified by relevant variations in clinical practice. Variations in fetal exclusion criteria for fetal surgery now occur for abnormal fetal DNA analysis, cerebral gray matter heterotopias, cleft lip, and anatomic levels outside of MOMS inclusion criteria.<sup><xref rid="R28" ref-type="bibr">28</xref></sup> Two procedures for fetal surgery are now used for placode closure, via hysterotomy or by fetoscopy. Variations exist also in indications for neurosurgical procedures to treat the comorbidities of myelomeningocele,<sup><xref rid="R33" ref-type="bibr">33</xref></sup> probably because there are no level 1 or 2 guidelines for any such neurosurgical procedure. It is therefore not surprising that variation also exists among spina bifida clinics participating in the NSBPR in frequencies of CSF diversion, ranging from 50% to 97%,<sup><xref rid="R25" ref-type="bibr">25</xref></sup> and in frequencies of Chiari decompression, ranging from 2% to 23%.<sup><xref rid="R26" ref-type="bibr">26</xref></sup> Finally, two procedures are used for CSF diversion: shunt insertion and ETV.</p><p id="P36">The NSBPR does not collect any prenatal data except the occurrence of fetal surgery. Therefore, we could not match postnatal surgery patients to fetal surgery patients for fetal surgery inclusion criteria. It is likely that this resulted in our postnatal surgery cohort having a greater frequency of patients with fetal surgery exclusion criteria than our fetal surgery cohort. The relevant fetal surgery exclusion criteria were absence of fetal hindbrain herniation, fetal anatomic level outside of MOMS inclusion criteria, fetal kyphosis, chromosomal abnormality, fetal physical anomalies not associated with myelomeningocele, and twin gestation. Literature searches revealed no reports of an association of any fetal surgery exclusion criterion with any of our four neurosurgical outcome procedures, with the exception of absence of fetal hindbrain herniation. Fetal hindbrain herniation was a fetal surgery exclusion criterion because it was thought to be associated with a lower frequency of postnatal hydrocephalus.<sup><xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R34" ref-type="bibr">34</xref></sup> There was no direct evidence for this until recently, when Nagaraj et al. found that only 13% (1 out of 8) of patients with no fetal hindbrain herniation had had shunt insertion.<sup><xref rid="R35" ref-type="bibr">35</xref></sup> Flanders et al. found that 23% of their postnatal surgery cohort had absent fetal hindbrain herniation<sup><xref rid="R20" ref-type="bibr">20</xref></sup> and it is likely that it was more frequent in our postnatal cohort as well. It is likely that the greater frequency of patients without fetal hindbrain herniation in our postnatal surgery cohort decreased the frequency of CSF diversion in this cohort, thereby decreasing the magnitude of the difference in frequencies of CSF diversion between cohorts. In spite of this, we found the difference in frequencies of CSF diversion to be significant. To say this another way, although we were not able to exclude patients without fetal hindbrain herniation from our postnatal surgery cohort, if we had been able to, excluding them would only have increased the magnitude of the significant effect, as the remaining infants in the postnatal surgery group would have had an even greater frequency of CSF diversion.</p><p id="P37">We then searched the literature for evidence that fetal anatomic levels of lesion were associated with the frequencies of any neurosurgical procedure in patients who had had postnatal surgery. For only one outcome, CSF diversion, had this been studied. No associations were found between fetal anatomic levels and CSF diversion frequencies in postnatal surgery cohorts in two studies.<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup></p><p id="P38">Because there are no data to support the idea that being unable to match our postnatal surgery patients to fetal surgery patients for fetal surgery exclusion affected the validity of our findings, we concluded that such matching was not mandatory for our study. This issue could be addressed someday by a consortium of fetal surgery centers using a set of common data elements (now in development<sup><xref rid="R36" ref-type="bibr">36</xref></sup>) and following patients prospectively.</p><p id="P39">Finally, we note that the three most recent post-MOMS single-center, observational studies comparing neurosurgical outcomes in fetal surgery and postnatal surgery cohorts also did not use fetal surgery exclusion criteria for selection of their postnatal surgery cohorts, thereby making them effectiveness studies as well.<sup><xref rid="R18" ref-type="bibr">18</xref>&#x02013;<xref rid="R20" ref-type="bibr">20</xref></sup></p><p id="P40">Our study may be useful in prenatal counseling and decision making by parents because it independently demonstrated that fetal surgery reduced the frequency of CSF diversion. Further, by studying a large national sample, it also addressed the generalizability of this finding. The analyzed experience of individual fetal surgery centers may also be helpful in decision making, since frequencies of CSF diversion by fetal surgery center vary some-what.<sup><xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr">19</xref></sup> Moreover, if an infant is cared for at a hospital where the CSF diversion frequency is low,<sup><xref rid="R37" ref-type="bibr">37</xref></sup> the advantage of fetal surgery to prevent CSF diversion may be relatively less. Our study also found that social determinants of health were differently distributed between our cohorts and, for some neurosurgical procedures, in the whole study population. This issue needs further study. Whether our study applies to regions of the world with fewer resources and/or a different ethical framework for treating patients with spina bifida is unknown.</p><p id="P41">The process of decision making is extremely complex<sup><xref rid="R38" ref-type="bibr">38</xref></sup> and must include discussions with parents about risks of fetal surgery to mothers and infants, and prognoses for other outcomes of fetal surgery, including cognitive development,<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R39" ref-type="bibr">39</xref></sup> ambulation,<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R39" ref-type="bibr">39</xref></sup> and bladder function,<sup><xref rid="R40" ref-type="bibr">40</xref></sup> all of which are beyond the scope of this study.</p><p id="P42">Although the MOMS showed no difference in survival between cohorts in school-age children,<sup><xref rid="R15" ref-type="bibr">15</xref></sup> whether fetal surgery improves life expectancy is unknown. However, our study provided evidence that fetal surgery reduced the frequencies of two major causes of mortality, hydrocephalus<sup><xref rid="R41" ref-type="bibr">41</xref></sup> and brainstem dysfunction from the Chiari II malformation.<sup><xref rid="R41" ref-type="bibr">41</xref>,<xref rid="R42" ref-type="bibr">42</xref></sup> Long-term follow-up studies will be necessary to address survival and other related issues.<sup><xref rid="R43" ref-type="bibr">43</xref></sup></p><p id="P43">Some of our study&#x02019;s limitations are inherent in the NSBPR. First, the reliability of the data collected was not independently validated. However, Centers for Disease Control and Prevention protocols were in place for data quality control, which included queries to spina bifida clinic sites about questionable entries.<sup><xref rid="R26" ref-type="bibr">26</xref></sup> Second, muscle function, and therefore motor level, cannot be as reliably assessed before 5 years old as after.<sup><xref rid="R44" ref-type="bibr">44</xref></sup> Third, results may not be generalizable to patients who are not cared for in a multidisciplinary spina bifida clinic in the United States or elsewhere. Finally, the NSBPR does not record any prenatal data, except for the occurrence of fetal surgery.</p><p id="P44">The NSBPR also did not record the site of fetal surgery. However, we note that eight of the 25 spina bifida clinics that contributed patients to our study are at institutions that offer fetal surgery. No single spina bifida clinic dominated the study population. The largest number of fetal surgery patients enrolled by a single spina bifida clinic was 60.</p><p id="P45">It is a strength of our study that we matched postnatal surgery patients with fetal surgery patients for spina bifida clinic, because there is variation by spina bifida clinic for some outcomes.<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R33" ref-type="bibr">33</xref></sup> Further, matching for spina bifida clinic also reduced variation in ascertainment of outcomes. Matching for date of birth (&#x000b1;3mo) controlled for the evolution in the neurosurgical management of comorbid conditions of myelomeningocele.<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup> Other strengths were the adjustments in analyses for covariates, the lack of investigator bias in ascertaining outcomes, and the study&#x02019;s independence from the MOMS investigators. The potential of using the NSBPR for outcomes studies of fetal surgery versus postnatal surgery was recognized by Flanders et al.<sup><xref rid="R20" ref-type="bibr">20</xref></sup></p></sec><sec id="S9"><title>CONCLUSIONS</title><p id="P46">In this comparative effectiveness study of fetal surgery versus postnatal surgery utilizing the NSBPR, we found a lower frequency of CSF diversion in fetal surgery patients, independent of ethnicity, insurance status, and spinal segmental level of motor function, and time-at-risk, concordant with the main finding of the MOMS.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Table S3 is included at end</label><media xlink:href="NIHMS1745495-supplement-Table_S3_is_included_at_end.pdf" orientation="portrait" id="d40e697" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Appendix S3</label><media xlink:href="NIHMS1745495-supplement-Appendix_S3.docx" orientation="portrait" id="d40e700" position="anchor"/></supplementary-material></sec></body><back><ack id="S11"><title>ACKNOWLEDGEMENTS</title><p id="P48">Additional investigators were as follows: Judy Thibadeau (Division of Human Development and Disability, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention [CDC], Atlanta, GA); J Richard Adams (Division of Developmental Behavioral Pediatrics, University of Texas Southwestern, Texas Scottish Rite Hospital, Dallas, TX); and Betsy Hopson (Division of Pediatric Neurosurgery, Children&#x02019;s Hospital of Alabama, Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA).</p><p id="P49">This study was funded by the CDC under the Cooperative Agreement for Research Approaches to Improve the Care and Outcomes of People Living with spina bifida. The authors thank the many individuals with spina bifida and their family members who participated in this research, without whom the NSBPR would not have been possible. The NSBPR has also been successful because of the contributions of the CDC, the Spina Bifida Association, and all members of the NSBPR Coordinating Committee (<xref rid="SD2" ref-type="supplementary-material">Appendix S3</xref>, <xref rid="SD2" ref-type="supplementary-material">online supporting information</xref>). The authors thank the reviewers from the NSBPR and from the CDC for their thoughtful critiques. The authors declare no conflict of interests. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. GW and JSW express their appreciation to the Kenneth and Elaine Jones Family, and the Jones-Guerrero Fund, for their support of the Duke Spina Bifida Clinic and its research. We also appreciate the helpful critiques of Dr Read Pukkila-Worley. This paper is dedicated to the memory of Dr Gregory S Liptak, a distinguished developmental pediatrician, whose vision and leadership were instrumental in establishing the NSBPR.</p></ack><fn-group><fn id="FN2"><p id="P500">Three additional investigators are listed in the <xref rid="S11" ref-type="other">Acknowledgements</xref>.</p></fn><fn id="FN3"><p id="P50">SUPPORTING INFORMATION</p><p id="P51">The following additional material may be found online:</p><p id="P52"><bold>Appendix S1:</bold> Myelomeningocele and spina bifida aperta.</p><p id="P53"><bold>Appendix S2:</bold> Methods.</p><p id="P54"><bold>Appendix S3:</bold> Members of the NSBPR Coordinating Committee.</p><p id="P55"><bold>Figure S1:</bold> Fetal and postnatal surgery patients by spina bifida clinic site of care.</p><p id="P56"><bold>Table S1:</bold> Unadjusted associations between demographic and clinical characteristics, and neurosurgery procedure outcomes, in the study population of fetal surgery and matched postnatal surgery patients</p><p id="P57"><bold>Table S2:</bold> Unadjusted associations between motor function spinal segmental level categories and neurosurgical procedure outcomes in the study population of fetal surgery and matched postnatal surgery patients</p><p id="P58"><bold>Table S3:</bold> Unadjusted associations of distributions of categories of spinal segmental levels of motor function (motor levels) with frequencies of CSF diversion in fetal surgery patients and separately in matched postnatal surgery patients</p></fn></fn-group><sec id="S10" sec-type="data-availability"><title>DATA AVAILABILITY STATEMENT</title><p id="P47">Data subject to third party restrictions.</p></sec><glossary><title>ABBREVIATIONS</title><def-list><def-item><term>CSF</term><def><p id="P59">Cerebrospinal fluid</p></def></def-item><def-item><term>ETV</term><def><p id="P60">Endoscopic third ventriculostomy</p></def></def-item><def-item><term>MOMS</term><def><p id="P61">Management of Myelomeningocele Study</p></def></def-item><def-item><term>NSBPR</term><def><p id="P62">National Spina Bifida Patient Registry</p></def></def-item></def-list></glossary><ref-list><title>REFERENCES</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Mitchell</surname><given-names>LE</given-names></name>, <name><surname>Adzick</surname><given-names>NS</given-names></name>, <name><surname>Melchionne</surname><given-names>J</given-names></name>, <etal/>
<article-title>Spina bifida</article-title>. <source>Lancet</source>
<year>2004</year>; <volume>364</volume>: <fpage>1885</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">15555669</pub-id></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Danzer</surname><given-names>E</given-names></name>, <name><surname>Joyeux</surname><given-names>L</given-names></name>, <name><surname>Flake</surname><given-names>AW</given-names></name>, <name><surname>Deprest</surname><given-names>J</given-names></name>. <article-title>Fetal surgical intervention for myelomeningocele: lessons learned, outcomes, and future implications</article-title>. <source>Dev Med Child Neurol</source>
<year>2020</year>; <volume>62</volume>: <fpage>417</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">31840814</pub-id></mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Dias</surname><given-names>MS</given-names></name>. <article-title>Neurosurgical management of myelomeningocele (spina bifida)</article-title>. <source>Pediatr Rev</source>
<year>2005</year>; <volume>26</volume>: <fpage>50</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">15687475</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Warf</surname><given-names>BC</given-names></name>, <name><surname>Campbell</surname><given-names>JW</given-names></name>. <article-title>Combined endoscopic third ventriculostomy and choroid plexus cauterization as primary treatment of hydrocephalus for infants with myelomeningocele: long-term results of a prospective intent-to-treat study in 115 East African infants</article-title>. <source>J Neurosurg Pediatr</source>
<year>2008</year>; <volume>2</volume>: <fpage>310</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">18976099</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>McLone</surname><given-names>DG</given-names></name>, <name><surname>Knepper</surname><given-names>P</given-names></name>. <article-title>The cause of Chiari II malformation: a unified theory</article-title>. <source>Pediatr Neurosci</source>
<year>1989</year>; <volume>15</volume>: <fpage>1</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">2699756</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Bowman</surname><given-names>RM</given-names></name>, <name><surname>Mohan</surname><given-names>A</given-names></name>, <name><surname>Ito</surname><given-names>J</given-names></name>, <name><surname>Seibly</surname><given-names>JM</given-names></name>, <name><surname>McLone</surname><given-names>DG</given-names></name>. <article-title>Tethered cord release: a long-term study in 114 patients</article-title>. <source>J Neurosurg Pediatr</source>
<year>2009</year>; <volume>3</volume>: <fpage>181</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">19338463</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Tulipan</surname><given-names>N</given-names></name>, <name><surname>Bruner</surname><given-names>JP</given-names></name>. <article-title>Myelomeningocele repair in utero: a report of three cases</article-title>. <source>Pediatr Neurosurg</source>
<year>1998</year>; <volume>28</volume>: <fpage>177</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">9732243</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Adzick</surname><given-names>NS</given-names></name>, <name><surname>Sutton</surname><given-names>LN</given-names></name>, <name><surname>Crombleholme</surname><given-names>TM</given-names></name>, <name><surname>Flake</surname><given-names>AW</given-names></name>. <article-title>Successful fetal surgery for Spina Bifida</article-title>. <source>Lancet</source>
<year>1998</year>; <volume>352</volume>: <fpage>1675</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">9853442</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Sutton</surname><given-names>LN</given-names></name>, <name><surname>Adzick</surname><given-names>NS</given-names></name>, <name><surname>Bilaniuk</surname><given-names>LT</given-names></name>, <etal/>
<article-title>Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for myelomeningocele</article-title>. <source>JAMA</source>
<year>1999</year>; <volume>282</volume>: <fpage>1826</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">10573273</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Bruner</surname><given-names>JP</given-names></name>, <name><surname>Tulipan</surname><given-names>N</given-names></name>, <name><surname>Paschall</surname><given-names>RL</given-names></name>, <etal/>
<article-title>Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus</article-title>. <source>JAMA</source>
<year>1999</year>; <volume>282</volume>: <fpage>1819</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">10573272</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Tulipan</surname><given-names>N</given-names></name>, <name><surname>Sutton</surname><given-names>LN</given-names></name>, <name><surname>Bruner</surname><given-names>JP</given-names></name>, <etal/>
<article-title>The effect of intrauterine myelomeningocele repair on the incidence of shunt-dependent hydrocephalus</article-title>. <source>Pediatr Neurosurg</source>
<year>2003</year>; <volume>38</volume>: <fpage>27</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">12476024</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Gross</surname><given-names>P</given-names></name>, <name><surname>Reed</surname><given-names>GT</given-names></name>, <name><surname>Engelmann</surname><given-names>R</given-names></name>, <name><surname>Kestle</surname><given-names>JR</given-names></name>. <article-title>Hydrocephalus research funding from the National Institutes of Health: a 10-year perspective</article-title>. <source>J Neurosurg Pediatr</source>
<year>2014</year>; <volume>13</volume>: <fpage>145</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">24313657</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Adzick</surname><given-names>NS</given-names></name>, <name><surname>Thom</surname><given-names>EA</given-names></name>, <name><surname>Spong</surname><given-names>CY</given-names></name>, <etal/>
<article-title>A randomized trial of prenatal versus postnatal repair of myelomeningocele</article-title>. <source>N Engl J Med</source>
<year>2011</year>; <volume>364</volume>: <fpage>993</fpage>&#x02013;<lpage>1004</lpage>.<pub-id pub-id-type="pmid">21306277</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Tulipan</surname><given-names>N</given-names></name>, <name><surname>Wellons</surname><given-names>JC</given-names><suffix>3rd</suffix></name>, <name><surname>Thom</surname><given-names>EA</given-names></name>, <etal/>
<article-title>Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement</article-title>. <source>J Neurosurg Pediatr</source>
<year>2015</year>; <volume>16</volume>: <fpage>613</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">26369371</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Houtrow</surname><given-names>AJ</given-names></name>, <name><surname>Thom</surname><given-names>EA</given-names></name>, <name><surname>Fletcher</surname><given-names>JM</given-names></name>, <etal/>
<article-title>Prenatal repair of myelomeningocele and school-age functional outcomes</article-title>. <source>Pediatrics</source>
<year>2020</year>; <volume>145</volume>: <fpage>e20191544</fpage>.<pub-id pub-id-type="pmid">31980545</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Riley</surname><given-names>JS</given-names></name>, <name><surname>Antiel</surname><given-names>RM</given-names></name>, <name><surname>Flake</surname><given-names>AW</given-names></name>, <etal/>
<article-title>Pediatric neurosurgeons&#x02019; views regarding prenatal surgery for myelomeningocele and the management of hydrocephalus: a national survey</article-title>. <source>Neurosurg Focus</source>
<year>2019</year>; <volume>47</volume>: <fpage>E8</fpage>.</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Zam&#x00142;y&#x00144;ski</surname><given-names>J</given-names></name>, <name><surname>Olejek</surname><given-names>A</given-names></name>, <name><surname>Koszutski</surname><given-names>T</given-names></name>, <etal/>
<article-title>Comparison of prenatal and postnatal treatments of spina bifida in Poland&#x02013;a non-randomized, single-center study</article-title>. <source>J Matern Fetal Neonatal Med</source>
<year>2014</year>; <volume>27</volume>: <fpage>1409</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">24156622</pub-id></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Cools</surname><given-names>M</given-names></name>, <name><surname>Northam</surname><given-names>W</given-names></name>, <name><surname>Goodnight</surname><given-names>W</given-names></name>, <etal/>
<article-title>Thirty-day medical and surgical readmission following prenatal versus postnatal myelomeningocele repair</article-title>. <source>Neurosurg Focus</source>
<year>2019</year>; <volume>47</volume>: <fpage>E14</fpage>.</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Riddle</surname><given-names>S</given-names></name>, <name><surname>Huddle</surname><given-names>R</given-names></name>, <name><surname>Lim</surname><given-names>FY</given-names></name>, <etal/>
<article-title>Morbidity and cost burden of prenatal myelomeningocele repair</article-title>. <source>J Matern Fetal Neonatal Med</source>
<comment>published online</comment>
<day>25</day>
<month>7</month>
<year>2019</year>, doi: <pub-id pub-id-type="doi">10.1080/14767058.2019.1645827</pub-id> (<comment>E-pub ahead of print</comment>).</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Flanders</surname><given-names>TM</given-names></name>, <name><surname>Heuer</surname><given-names>GG</given-names></name>, <name><surname>Madsen</surname><given-names>PJ</given-names></name>, <etal/>
<article-title>Detailed analysis of hydrocephalus and hindbrain herniation after prenatal and postnatal myelomeningocele closure: report from a single institution</article-title>. <source>Neurosurgery</source>
<year>2020</year>; <volume>86</volume>: <fpage>637</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">31432079</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Thibadeau</surname><given-names>JK</given-names></name>, <name><surname>Ward</surname><given-names>EA</given-names></name>, <name><surname>Soe</surname><given-names>MM</given-names></name>, <etal/>
<article-title>Testing the feasibility of a National Spina Bifida Patient Registry</article-title>. <source>Birth Defects Res A Clin Mol Teratol</source>
<year>2013</year>; <volume>97</volume>: <fpage>36</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">23125114</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Sawin</surname><given-names>KJ</given-names></name>, <name><surname>Liu</surname><given-names>T</given-names></name>, <name><surname>Ward</surname><given-names>E</given-names></name>, <etal/>
<article-title>The National Spina Bifida Patient Registry: profile of a large cohort of participants from the first 10 clinics</article-title>. <source>J Pediatr</source>
<year>2015</year>; <volume>166</volume>: <fpage>444</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">25444012</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Schechter</surname><given-names>MS</given-names></name>, <name><surname>Liu</surname><given-names>T</given-names></name>, <name><surname>Soe</surname><given-names>M</given-names></name>, <etal/>
<article-title>Sociodemographic attributes and spina bifida outcomes</article-title>. <source>Pediatrics</source>
<year>2015</year>; <volume>135</volume>: <fpage>e957</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">25780069</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Alabi</surname><given-names>NB</given-names></name>, <name><surname>Thibadeau</surname><given-names>J</given-names></name>, <name><surname>Wiener</surname><given-names>JS</given-names></name>, <etal/>
<article-title>surgeries and health outcomes among patients with spina bifida</article-title>. <source>Pediatrics</source>
<year>2018</year>; <volume>142</volume>: <fpage>e20173730</fpage>.<pub-id pub-id-type="pmid">30158199</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>I</given-names></name>, <name><surname>Hopson</surname><given-names>B</given-names></name>, <name><surname>Aban</surname><given-names>I</given-names></name>, <etal/>
<article-title>Treated hydrocephalus in individuals with myelomeningocele in the National Spina Bifida Patient Registry</article-title>. <source>J Neurosurg Pediatr</source>
<year>2018</year>; <volume>22</volume>: <fpage>646</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">30141753</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>I</given-names></name>, <name><surname>Hopson</surname><given-names>B</given-names></name>, <name><surname>Aban</surname><given-names>I</given-names></name>, <etal/>
<article-title>Decompression for Chiari malformation type II in individuals with myelomeningocele in the National Spina Bifida Patient Registry</article-title>. <source>J Neurosurg Pediatr</source>
<year>2018</year>; <volume>22</volume>: <fpage>652</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">30141752</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Shah</surname><given-names>BR</given-names></name>, <name><surname>Drozda</surname><given-names>J</given-names></name>, <name><surname>Peterson</surname><given-names>ED</given-names></name>. <article-title>Leveraging observational registries to inform comparative effectiveness research</article-title>. <source>Am Heart J</source>
<year>2010</year>; <volume>160</volume>: <fpage>8</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">20598966</pub-id></mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Moise</surname><given-names>KJ</given-names><suffix>Jr</suffix></name>, <name><surname>Moldenhauer</surname><given-names>JS</given-names></name>, <name><surname>Bennett</surname><given-names>KA</given-names></name>, <etal/>
<article-title>Current selection criteria and perioperative therapy used for fetal myelomeningocele surgery</article-title>. <source>Obstet Gynecol</source>
<year>2016</year>; <volume>127</volume>: <fpage>593</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">26855109</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Zou</surname><given-names>G</given-names></name>
<article-title>A modified poisson regression approach to prospective studies with binary data</article-title>. <source>Am J Epidemiol</source>
<year>2004</year>; <volume>159</volume>: <fpage>702</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">15033648</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Yu</surname><given-names>KF</given-names></name>. <article-title>What&#x02019;s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes</article-title>. <source>JAMA</source>
<year>1998</year>; <volume>280</volume>: <fpage>1690</fpage>&#x02013;<lpage>1</lpage>.<pub-id pub-id-type="pmid">9832001</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Kelly</surname><given-names>MS</given-names></name>, <name><surname>Benjamin</surname><given-names>DK</given-names></name>, <name><surname>Puopolo</surname><given-names>KM</given-names></name>, <etal/>
<article-title>Postnatal cytomegalovirus infection and the risk for bronchopulmonary dysplasia</article-title>. <source>JAMA Pediatr</source>
<year>2015</year>; <volume>169</volume>: <fpage>e153785</fpage>.<pub-id pub-id-type="pmid">26642118</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Knol</surname><given-names>MJ</given-names></name>, <name><surname>Le Cessie</surname><given-names>S</given-names></name>, <name><surname>Algra</surname><given-names>A</given-names></name>, <name><surname>Vandenbroucke</surname><given-names>JP</given-names></name>, <name><surname>Groenwold</surname><given-names>RH</given-names></name>. <article-title>Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression</article-title>. <source>CMAJ</source>
<year>2012</year>; <volume>184</volume>: <fpage>895</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">22158397</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Alford</surname><given-names>EN</given-names></name>, <name><surname>Hopson</surname><given-names>BD</given-names></name>, <name><surname>Safyanov</surname><given-names>F</given-names></name>, <etal/>
<article-title>Care management and contemporary challenges in spina bifida: a practice preference survey of the American Society of Pediatric Neurosurgeons</article-title>. <source>J Neurosurg Pediatr</source>
<year>2019</year>; <volume>24</volume> (<issue>5</issue>): <fpage>539</fpage>&#x02013;<lpage>48</lpage> (<comment>E-pub ahead of print</comment>).</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Walsh</surname><given-names>DS</given-names></name>, <name><surname>Adzick</surname><given-names>NS</given-names></name>, <name><surname>Sutton</surname><given-names>LN</given-names></name>, <name><surname>Johnson</surname><given-names>MP</given-names></name>. <article-title>The rationale for in utero repair of myelomeningocele</article-title>. <source>Fetal Diagn Ther</source>
<year>2001</year>; <volume>16</volume>: <fpage>312</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">11509855</pub-id></mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Nagaraj</surname><given-names>UD</given-names></name>, <name><surname>Bierbrauer</surname><given-names>KS</given-names></name>, <name><surname>Zhang</surname><given-names>B</given-names></name>, <name><surname>Peiro</surname><given-names>JL</given-names></name>, <name><surname>Kline-Fath</surname><given-names>BM</given-names></name>. <article-title>Hindbrain herniation in Chiari II malformation on fetal and postnatal MRI</article-title>. <source>AJNR Am J Neuroradiol</source>
<year>2017</year>; <volume>38</volume>: <fpage>1031</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">28279990</pub-id></mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Altoukhi</surname><given-names>S</given-names></name>, <name><surname>Whitehead</surname><given-names>CL</given-names></name>, <name><surname>Ryan</surname><given-names>G</given-names></name>, <etal/>
<article-title>Development of a Core outcome set for fetal Myelomeningocele (COSMiC): study protocol</article-title>. <source>Trials</source>
<year>2020</year>; <volume>21</volume>: <fpage>732</fpage>.<pub-id pub-id-type="pmid">32825852</pub-id></mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Chakraborty</surname><given-names>A</given-names></name>, <name><surname>Crimmins</surname><given-names>D</given-names></name>, <name><surname>Hayward</surname><given-names>R</given-names></name>, <name><surname>Thompson</surname><given-names>D</given-names></name>. <article-title>Toward reducing shunt placement rates in patients with myelomeningocele</article-title>. <source>J Neurosurg Pediatr</source>
<year>2008</year>; <volume>1</volume>: <fpage>361</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">18447669</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Van Calenbergh</surname><given-names>F</given-names></name>, <name><surname>Joyeux</surname><given-names>L</given-names></name>, <name><surname>Deprest</surname><given-names>J</given-names></name>. <article-title>Maternal-fetal surgery for myelomeningocele: some thoughts on ethical, legal, and psychological issues in a Western European situation</article-title>. <source>Childs Nerv Syst</source>
<year>2017</year>; <volume>33</volume>: <fpage>1247</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">28536839</pub-id></mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><name><surname>Farmer</surname><given-names>DL</given-names></name>, <name><surname>Thom</surname><given-names>EA</given-names></name>, <name><surname>Brock</surname><given-names>JW</given-names><suffix>3rd</suffix></name>, <etal/>
<article-title>The Management of Myelomeningocele Study: full cohort 30-month pediatric outcomes</article-title>. <source>Am J Obstet Gynecol</source>
<year>2018</year>; <volume>218</volume>: <fpage>256</fpage>.<fpage>e1</fpage>&#x02013;<lpage>e13</lpage>.<pub-id pub-id-type="pmid">29246577</pub-id></mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name><surname>Brock</surname><given-names>JW</given-names><suffix>3rd</suffix></name>, <name><surname>Thomas</surname><given-names>JC</given-names></name>, <name><surname>Baskin</surname><given-names>LS</given-names></name>, <etal/>
<article-title>Effect of prenatal repair of myelomeningocele on urological outcomes at school age</article-title>. <source>J Urol</source>
<year>2019</year>; <volume>202</volume>: <fpage>812</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">31075056</pub-id></mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>Oakeshott</surname><given-names>P</given-names></name>, <name><surname>Hunt</surname><given-names>GM</given-names></name>, <name><surname>Poulton</surname><given-names>A</given-names></name>, <name><surname>Reid</surname><given-names>F</given-names></name>. <article-title>Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study</article-title>. <source>Dev Med Child Neurol</source>
<year>2010</year>; <volume>52</volume>: <fpage>749</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">20015251</pub-id></mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><name><surname>Worley</surname><given-names>G</given-names></name>, <name><surname>Schuster</surname><given-names>JM</given-names></name>, <name><surname>Oakes</surname><given-names>WJ</given-names></name>. <article-title>Survival at 5 years of a cohort of newborn infants with myelomeningocele</article-title>. <source>Dev Med Child Neurol</source>
<year>1996</year>; <volume>38</volume>: <fpage>816</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">8810713</pub-id></mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><name><surname>Oakeshott</surname><given-names>P</given-names></name>, <name><surname>Reid</surname><given-names>F</given-names></name>, <name><surname>Poulton</surname><given-names>A</given-names></name>, <etal/>
<article-title>Neurological level at birth predicts survival to the mid-40s and urological deaths in open spina bifida: a complete prospective cohort study</article-title>. <source>Dev Med Child Neurol</source>
<year>2015</year>; <volume>57</volume>: <fpage>634</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">25683691</pub-id></mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><name><surname>McDonald</surname><given-names>CM</given-names></name>, <name><surname>Jaffe</surname><given-names>KM</given-names></name>, <name><surname>Shurtleff</surname><given-names>DB</given-names></name>. <article-title>Assessment of muscle strength in children with meningomyelocele: accuracy and stability of measurements over time</article-title>. <source>Arch Phys Med Rehabil</source>
<year>1986</year>; <volume>67</volume>: <fpage>855</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">3800612</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1:</label><caption><p id="P63">Number of fetal surgery patients, by year of birth (<italic>n</italic>=321). A higher proportion of patients born in 2011 and after (208 out of 1473, 14%) had fetal surgery compared with before 2011 (113 out of 3399, 3%; <italic>p</italic>&#x0003c;0.001).</p></caption><graphic xlink:href="nihms-1745495-f0001"/></fig><table-wrap id="T1" position="float" orientation="landscape"><label>Table 1:</label><caption><p id="P64">Unadjusted comparisons of demographic characteristics, categories of spinal segmental level of motor function, and the age at last visit recorded in the NSBPR between fetal surgery patients (<italic>n</italic>=298) and postnatal surgery patients matched for date of birth (&#x000b1;3mo) (<italic>n</italic>=648), assessed when patients in both cohorts were at least 12 months of age</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Covariate</th><th align="left" valign="middle" rowspan="1" colspan="1">Fetal surgery, <italic>n</italic> (%)</th><th align="left" valign="middle" rowspan="1" colspan="1">Postnatal surgery, <italic>n</italic> (%)</th><th align="left" valign="middle" rowspan="1" colspan="1">IRR (95% CI); <italic>p</italic></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Male sex</td><td align="left" valign="middle" rowspan="1" colspan="1">147/298 (49)</td><td align="left" valign="middle" rowspan="1" colspan="1">321/648 (50)</td><td align="left" valign="middle" rowspan="1" colspan="1">1.00 (0.76&#x02013;1.32); 0.99</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Female sex</td><td align="left" valign="middle" rowspan="1" colspan="1">151/298 (51)</td><td align="left" valign="middle" rowspan="1" colspan="1">327/648 (50)</td><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Non-Hispanic white</td><td align="left" valign="middle" rowspan="1" colspan="1">236/285 (83)</td><td align="left" valign="middle" rowspan="1" colspan="1">404/631 (64)</td><td align="left" valign="middle" rowspan="1" colspan="1">3.06 (2.07&#x02013;4.54); &#x0003c;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Non-Hispanic black</td><td align="left" valign="middle" rowspan="1" colspan="1">10/285 (4)</td><td align="left" valign="middle" rowspan="1" colspan="1">75/631 (12)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.30 (0.15&#x02013;0.58); &#x0003c;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hispanic</td><td align="left" valign="middle" rowspan="1" colspan="1">34/287 (12)</td><td align="left" valign="middle" rowspan="1" colspan="1">136/641 (21)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.41 (0.26&#x02013;0.66); &#x0003c;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Private insurance</td><td align="left" valign="middle" rowspan="1" colspan="1">218/298 (73)</td><td align="left" valign="middle" rowspan="1" colspan="1">335/648 (52)</td><td align="left" valign="middle" rowspan="1" colspan="1">2.76 (2.00&#x02013;3.81); &#x0003c;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sacral level</td><td align="left" valign="middle" rowspan="1" colspan="1">102 (34)</td><td align="left" valign="middle" rowspan="1" colspan="1">163 (25)</td><td align="left" valign="middle" rowspan="1" colspan="1">Reference</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Low lumbar level</td><td align="left" valign="middle" rowspan="1" colspan="1">81 (27)</td><td align="left" valign="middle" rowspan="1" colspan="1">151 (23)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.94 (0.64&#x02013;1.37); 0.75</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Mid-lumbar level</td><td align="left" valign="middle" rowspan="1" colspan="1">79 (27)</td><td align="left" valign="middle" rowspan="1" colspan="1">176 (27)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.75 (0.50&#x02013;1.11); 0.15</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">High lumbar level</td><td align="left" valign="middle" rowspan="1" colspan="1">16 (5)</td><td align="left" valign="middle" rowspan="1" colspan="1">87 (13)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.30 (0.16&#x02013;0.55); &#x0003c;0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Thoracic level</td><td align="left" valign="middle" rowspan="1" colspan="1">20 (7)</td><td align="left" valign="middle" rowspan="1" colspan="1">71 (11)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.47 (0.26&#x02013;0.84); 0.01</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age at last visit in years</td><td align="left" valign="middle" rowspan="1" colspan="1">3.67 (1.42&#x02013;11.09)</td><td align="left" valign="middle" rowspan="1" colspan="1">4.08 (2.00&#x02013;11.50)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.02 (&#x02212;0.13 to 0.17); 0.82</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P65">All patients had myelomeningocele, were born 1997 through 2017, and were enrolled in the National Spina Bifida Patient Registry (NSBPR) 2009 through 2017. The significance of differences between cohorts in demographic characteristics was assessed by univariable Poisson regression. The significance of differences in frequencies of patients in categories of spinal segmental level of motor function was assessed by Poisson univariable regression, and the significance of differences in age at last visit recorded in the NSBPR was assessed by univariable Poisson linear regression. Percentages may not total 100% because of rounding. IRR, incidence rate ratio; CI, confidence interval.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="landscape"><label>Table 2:</label><caption><p id="P66">Comparison of neurosurgical procedure outcomes between fetal surgery (<italic>n</italic>=248) and postnatal surgery (<italic>n</italic>=698) patients assessed when patients in both cohorts were at least 12 months of age</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Outcome</th><th align="left" valign="bottom" rowspan="1" colspan="1">Fetal surgery, <italic>n</italic> (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Postnatal surgery, <italic>n</italic> (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Unadjusted IRR (95% CI); <italic>p</italic></th><th align="left" valign="bottom" rowspan="1" colspan="1">Adjusted IRR<sup><xref rid="TFN3" ref-type="table-fn">a</xref></sup> (95% CI); <italic>p</italic></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">CSF diversion at last visit (shunted or ETV)<sup><xref rid="TFN3" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">110/239 (46)</td><td align="left" valign="top" rowspan="1" colspan="1">349/441 (79)</td><td align="left" valign="top" rowspan="1" colspan="1">0.58 (0.50&#x02013;0.67); &#x0003c;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.61 (0.53&#x02013;0.71); &#x0003c;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Shunt revision ever/shunted patients at last visit<sup><xref rid="TFN4" ref-type="table-fn">b</xref>,<xref rid="TFN5" ref-type="table-fn">c</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">51/96 (53)</td><td align="left" valign="top" rowspan="1" colspan="1">185/336 (55)</td><td align="left" valign="top" rowspan="1" colspan="1">0.89 (0.71&#x02013;1.12); 0.32</td><td align="left" valign="top" rowspan="1" colspan="1">0.86 (0.67&#x02013;1.10); 0.23</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chiari decompression<sup><xref rid="TFN4" ref-type="table-fn">b</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">10/298 (3)</td><td align="left" valign="top" rowspan="1" colspan="1">45/648 (7)</td><td align="left" valign="top" rowspan="1" colspan="1">0.50 (0.26&#x02013;0.96); 0.04</td><td align="left" valign="top" rowspan="1" colspan="1">0.41 (0.19&#x02013;0.88); 0.02</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tethered cord release<sup><xref rid="TFN4" ref-type="table-fn">b</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">54/298 (18)</td><td align="left" valign="top" rowspan="1" colspan="1">102/648 (16)</td><td align="left" valign="top" rowspan="1" colspan="1">1.22 (0.94&#x02013;1.59); 0.13</td><td align="left" valign="top" rowspan="1" colspan="1">1.11 (0.84&#x02013;1.47); 0.46</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p id="P67">All patients had myelomeningocele, were born 1997 through 2017, and were enrolled in the National Spina Bifida Patient Registry (NSBPR) 2009 through 2017. Outcomes were assessed at last visit recorded in the Registry. Univariable Poisson regression was used for unadjusted analyses. Multivariable Poisson regression was used to adjust for the covariates of non-Hispanic white, insurance status, motor function segmental level, and age at last visit in the NSBPR, in determining adjusted incidence rate ratios (IRRs), 95% confidence intervals (CIs), and significance of differences.</p></fn><fn id="TFN3"><label>a</label><p id="P68">In matched patients &#x02265;12 months old.</p></fn><fn id="TFN4"><label>b</label><p id="P69">In patients of all ages.</p></fn><fn id="TFN5"><label>c</label><p id="P70">For shunt revision in shunted patients, age at shunt insertion was also a covariate.</p></fn></table-wrap-foot></table-wrap><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>What this paper adds</title></caption><list list-type="bullet" id="L2"><list-item><p id="P71">Fetal surgery was associated with lower frequencies of cerebrospinal fluid diversion and decompression of Chiari II malformation than postnatal surgery.</p></list-item><list-item><p id="P72">Frequencies of ventriculoperitoneal shunt revision and tethered cord release were not significantly different between cohorts.</p></list-item></list></boxed-text></floats-group></article>